HCAT Stock Recent News

SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Daniel LeSueur - Chief Operating Officer Daniel D. Burton - CEO & Director Jack Knight - Corporate Participant Jason Alger - Chief Financial Officer Conference Call Participants Daniel R.

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago.

Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY , Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints. As a result, Mr.

SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. “For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric.

Health Catalyst (HCAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

I rate Health Catalyst a buy, driven by strong turnaround momentum and the transformative Ignite platform fueling faster growth and higher margins. Ignite's modular, lower-cost structure accelerates sales cycles, improves gross margins, and opens significant upsell opportunities within HCAT's large existing customer base. Recent financials show accelerating revenue growth and strong client additions, supporting management's FY25 guidance and signaling a potential inflection point for the business.

SALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector 1x1 Conference, being held in Boston, on Tuesday, June 3, 2025. The Goldman Sachs 46th Annual Global Healthcare Conference, being held in Miami, on Tuesday, June 10, 2025.

Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Richard Close - Canaccord Genuity Daniel Grosslight - Citi Jenny Shen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Sarah James - Cantor Operator Welcome to the Health Catalyst First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.